Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug gains FDA approval or passes a clinical trial, there can be big upside.
The Trump administration has promised reforms in the health care sector, such as changing the bidding process for drugs and shortening the FDA approval process. It has yet to be seen how much headway the White House can actually make with these reforms.
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Short interest in Pfizer Inc. (NYSE: PFE) fell sharply to 110.37 million shares from the previous 137.21 million. Its shares were last seen at $34.05, within a 52-week trading range of $28.74 to $37.39.
The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 17.23 million from 18.98 million in the previous period. Its shares were trading at $65.89, in a 52-week range of $51.33 to $66.80.
Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) short interest fell to 20.51 million shares, compared to the previous level of 27.97 million. Shares were trading at $32.96, in a 52-week range of $31.90 to $59.35.
The sharp rise in Bristol-Myers Squibb Co. (NYSE: BMY) short interest was to 47.39 million shares, from the previous reading of 15.95 million. Shares were trading at $57.99, within a 52-week range of $46.01 to $77.12.
The number of shares short in AbbVie Inc. (NYSE: ABBV) decreased to 29.95 million, compared to the previous 31.63 million. The stock was trading at $64.50, in a 52-week range of $54.41 to $68.12.
Eli Lilly and Co.’s (NYSE: LLY) short interest decreased to 12.15 million shares from the previous 12.37 million. The stock was trading at $84.55. The 52-week range is $64.18 to $84.77.
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.